App IDs shortages, resolved shortages, product discontinuation; can be used to report shortages.
Include defining minimum requirement necessary for establishing doctor-patient relationship.
Research suggests tenofovir/emtricitabine doesn't need to be taken daily, but more study still needed.
Increased mortality at all CD4 cell count strata, although absolute incidence is low.
Commonwealth Fund foresees only modest increases in use of services.
Devices include remote heartbeat monitor, fitness smart socks, and devices for monitoring glucose.
Studies show high rates for all-oral, interferon-free 3D plus ribavirin regimen, ledipasvir sofosbuvir.
Findings suggest there's a long way to go in containing spread of the disease.
Fear of corporate defamation lawsuits should not prevent examination of corporate products.
Physicians may want to be proactive by detailing costs and options for patients.
myCME is free, fast, and customized just for you!
Already a myCME member?Sign In Now »